Mariam Mansour Staff Profile
Prescient Therapeutics: Mariam Mansour, PhD Mariam Mansour, PhD, Director of Clinical Development and Translational Sciences...
Prescient Therapeutics: Mariam Mansour, PhD Mariam Mansour, PhD, Director of Clinical Development and Translational Sciences...
Prescient Therapeutics: Professor H. Miles Prince Professor H. Miles Prince AM, the Principal Investigator for...
A strong and diversified pipeline has led Pitt Street Research to value Prescient Therapeutics Ltd (ASX:PTX,...
Prescient Therapeutics update report 2024 08 29
Clinical stage oncology company Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) had a cash and term deposit balance of $14.5...
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF), a clinical-stage oncology company developing personalised therapies for cancer, has...
Prescient Therapeutics, an ASX-listed company, is engaged in the development of drugs targeting various forms...
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) CEO and managing director Steven Yatomi-Clarke sits down with Jonathan Jackson...
Clinical-stage oncology company Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) has been invited to present PTX-100 Phase 1b results...
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) will present results of its Phase 1b study of PTX-100 in...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.